We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$20.7B
AUM Growth
-$166M
Cap. Flow
-$582M
Cap. Flow %
-2.82%
Top 10 Hldgs %
30.44%
Holding
2,896
New
52
Increased
415
Reduced
1,909
Closed
89

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.1M
2
AAPL icon
Apple
AAPL
+$58M
3
MSFT icon
Microsoft
MSFT
+$49.2M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
5
AL
Air Lease Corp
AL
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 30.28%
2 Financials 13.29%
3 Healthcare 10.43%
4 Consumer Discretionary 10.39%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IR icon
476
Ingersoll Rand
IR
$32.4B
$6.88M 0.03%
86,812
-3,623
-4% -$286K
ORA icon
477
Ormat Technologies
ORA
$7.01B
$6.87M 0.03%
62,204
-3,767
-6% -$412K
HIMS icon
478
Hims & Hers Health
HIMS
$6.82B
$6.87M 0.03%
211,476
-3,159
-1% -$135K
AVB icon
479
AvalonBay Communities
AVB
$26.4B
$6.86M 0.03%
37,849
-1,416
-4% -$257K
FG icon
480
F&G Annuities & Life
FG
$3.57B
$6.85M 0.03%
222,158
+14,315
+7% +$448K
NCLH icon
481
Norwegian Cruise Line
NCLH
$8.8B
$6.85M 0.03%
306,936
-1,599
-0.5% -$33.8K
ULTA icon
482
Ulta Beauty
ULTA
$22.2B
$6.84M 0.03%
11,299
-393
-3% -$216K
GH icon
483
Guardant Health
GH
$21.8B
$6.84M 0.03%
66,922
-3,135
-4% -$280K
MTD icon
484
Mettler-Toledo International
MTD
$28.6B
$6.83M 0.03%
4,902
-215
-4% -$300K
FNF icon
485
Fidelity National Financial
FNF
$13B
$6.8M 0.03%
124,568
-6,788
-5% -$386K
RJF icon
486
Raymond James Financial
RJF
$34.5B
$6.79M 0.03%
42,295
-1,821
-4% -$294K
OHI icon
487
Omega Healthcare
OHI
$14B
$6.77M 0.03%
152,617
-7,134
-4% -$307K
AA icon
488
Alcoa
AA
$13.4B
$6.72M 0.03%
126,527
-6,541
-5% -$268K
FANG icon
489
Diamondback Energy
FANG
$55.8B
$6.71M 0.03%
44,668
-2,059
-4% -$304K
MEDP icon
490
Medpace
MEDP
$16.4B
$6.71M 0.03%
11,952
-514
-4% -$292K
BBIO icon
491
BridgeBio Pharma
BBIO
$16.1B
$6.7M 0.03%
87,610
-3,973
-4% -$261K
FSLR icon
492
First Solar
FSLR
$24B
$6.7M 0.03%
25,631
-882
-3% -$222K
MTZ icon
493
MasTec
MTZ
$23.2B
$6.66M 0.03%
30,616
-1,530
-5% -$321K
GGG icon
494
Graco
GGG
$13.1B
$6.64M 0.03%
81,015
-4,154
-5% -$342K
ADM icon
495
Archer Daniels Midland
ADM
$38.8B
$6.62M 0.03%
115,159
-4,008
-3% -$240K
HSY icon
496
Hershey
HSY
$37.4B
$6.61M 0.03%
36,324
-1,215
-3% -$222K
CSL icon
497
Carlisle Companies
CSL
$14.9B
$6.59M 0.03%
20,601
-1,564
-7% -$507K
EFX icon
498
Equifax
EFX
$21.3B
$6.59M 0.03%
30,353
-1,380
-4% -$302K
IRM icon
499
Iron Mountain
IRM
$37.3B
$6.56M 0.03%
79,043
-2,469
-3% -$231K
RGA icon
500
Reinsurance Group of America
RGA
$16.2B
$6.53M 0.03%
32,114
-1,856
-5% -$359K

Similar funds

MetLife Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, MetLife Investment Management held 2,896 positions worth $20.7B, down 0.8% from $20.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 4.9%. MetLife Investment Management opened 52 new positions and exited 89, leaving the 2,896-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2025 buy was RTX Corp: 321,368 shares worth $58.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $54.6M increase.
  • MetLife Investment Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $65.1M.
  • MetLife Investment Management fully exited Kellanova in Q4 2025, selling an estimated $5.48M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.7B portfolio in Q4 2025.
  • MetLife Investment Management opened 52 new positions and closed 89 in Q4 2025.
  • MetLife Investment Management's portfolio value fell 0.8% quarter-over-quarter to $20.7B.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.